NASDAQ : VTRS
Viatris Inc. — Key statistics
Healthcare · Drug Manufacturers - Specialty & Generic · United States
Last price 19.2 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 22.05B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 21.44B |
| Enterprise Value | 33.56B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | Aug 21, 2026 |
Shares
| Measure | Value |
|---|
| Current Share Class | 1.15B |
| Shares Outstanding | 1.15B |
| Shares Change (YoY) | -2.45% |
| Shares Change (QoQ) | -1.02% |
| Owned by Insiders (%) | 0.43% |
| Owned by Institutions (%) | 96.03% |
| Float | 1.14B |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | 7.31 |
| PS Ratio | 1.46 |
| Forward PS | 1.44 |
| PB Ratio | 1.51 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 10.97 |
| P/OCF Ratio | 9.20 |
| PEG Ratio | 2.52 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 2.28 |
| EV / EBITDA | 7.82 |
| EV / EBIT | 21.40 |
| EV / FCF | 17.17 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.58 |
| Quick Ratio | 0.82 |
| Debt / Equity | 0.96 |
| Debt / EBITDA | 3.11 |
| Debt / FCF | 6.97 |
| Interest Coverage | 3.27 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -2.75% |
| Return on Assets (ROA) | 2.67% |
| Return on Invested Capital (ROIC) | 5.89% |
| Return on Capital Employed (ROCE) | 5.46% |
| Weighted Average Cost of Capital (WACC) | 6.57% |
| Revenue Per Employee | $491,243 |
| Profits Per Employee | -$13,690 |
| Employee Count | 30,000 |
| Asset Turnover | 0.40 |
| Inventory Turnover | 2.15 |
Taxes
| Measure | Value |
|---|
| Income Tax | -251.50M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.86 |
| 52-Week Price Change | +80.21% |
| 50-Day Moving Average | 17.50 |
| 200-Day Moving Average | 15.92 |
| Relative Strength Index (RSI) | 57.83 |
| Average Volume (20 Days) | 8,695,162 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 37.93M |
| Short Previous Month | 42.04M |
| Short % of Shares Out | 3.30% |
| Short % of Float | 3.32% |
| Short Ratio (days to cover) | 4.13 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 14.74B |
| Gross Profit | 5.94B |
| Operating Income | 1.57B |
| Pretax Income | -662.20M |
| Net Income | -410.70M |
| EBITDA | 4.29B |
| EBIT | 1.57B |
| Loss Per Share | -$0.35 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 1.51B |
| Total Debt | 13.62B |
| Net Cash | -12.11B |
| Net Cash Per Share | -$10.55 |
| Equity (Book Value) | 14.26B |
| Book Value Per Share | 12.34 |
| Working Capital | 3.71B |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 2.33B |
| Capital Expenditures | -376.00M |
| Depreciation & Amortization | 2.72B |
| Net Borrowing | -923.50M |
| Free Cash Flow | 1.95B |
| FCF Per Share | $1.70 |
Margins
| Measure | Value |
|---|
| Gross Margin | 40.31% |
| Operating Margin | 10.64% |
| Pretax Margin | -4.49% |
| Profit Margin | -2.79% |
| EBITDA Margin | 29.13% |
| EBIT Margin | 10.64% |
| FCF Margin | 13.26% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | $0.48 |
| Dividend Yield | 2.57% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | 28.20% |
| Buyback Yield | 2.45% |
| Shareholder Yield | 5.02% |
| Earnings Yield | -1.90% |
| FCF Yield | 9.12% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $20.00 |
| Price Target Difference | 7.12% |
| Analyst Consensus | Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (3Y) | 3.35% |
| EPS Growth Forecast (3Y) | 7.25% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Oct 9, 2003 |
| Split Type | Forward |
| Split Ratio | 1.5:1 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 1.1 |
| Piotroski F-Score | 6 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |